Lifestyle factors as mediators of area-level socio-economic differentials in cardiovascular disease risk factors. The Tromsø Study.
Area level socio-economic status
Cardiovascular disease
Mediation
Risk factors
Journal
SSM - population health
ISSN: 2352-8273
Titre abrégé: SSM Popul Health
Pays: England
ID NLM: 101678841
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
10
06
2022
revised:
15
09
2022
accepted:
23
09
2022
entrez:
7
10
2022
pubmed:
8
10
2022
medline:
8
10
2022
Statut:
epublish
Résumé
Cardiovascular disease (CVD) is a leading cause of death and disability and living in areas with low socio-economic status (SES) is associated with increased risk of CVD. Lifestyle factors such as smoking, physical inactivity, an unhealthy diet and harmful alcohol use are main risk factors that contribute to other modifiable risk factors, such as hypertension, raised blood cholesterol, obesity, and diabetes. The potential impact of area-level socio-economic status (ASES) on metabolic CVD risk factors via lifestyle behaviors independent of individual SES has not been investigated previously. To estimate associations of ASES with CVD risk factors and the mediating role of lifestyle behaviors independent of individual-level SES. In this cross-sectional study, we included 19,415 participants (52% women) from the seventh survey of the Tromsø Study (2015-2016) (Tromsø7). The exposure variable ASES was created by aggregating individual-level SES variables (education, income, housing ownership) at the geographical subdivision level. Individual-level SES data and geographical subdivision of Tromsø municipality (36 areas) were obtained from Statistics Norway. Variables from questionnaires and clinical examinations obtained from Tromsø7 were used as mediators (smoking, snuff, alcohol, and physical activity), while the outcome variables were body mass index (BMI), total/high-density lipoprotein (HDL) cholesterol ratio, waist circumference, hypertension, diabetes. Mediation and mediated moderation analysis were performed with age as a moderator, stratified by sex. ASES was significantly associated with all outcome variables. CVD risk factor level declined with an increase in ASES. These associations were mediated by differences in smoking habits, alcohol use and physical activity. The associations of ASES with total/HDL cholesterol ratio and waist circumference (women) were moderated by age, and the moderating effects were mediated by smoking and physical activity in both sexes. The largest mediated effects were seen in the associations of ASES with total/HDL cholesterol ratio, with the mediators accounting for 43% of the observed effects. Living in lower SES areas is associated with increased CVD risk due to unhealthy lifestyle behaviors, such as smoking, alcohol use and physical inactivity. These associations were stronger in women and among older participants.
Identifiants
pubmed: 36203474
doi: 10.1016/j.ssmph.2022.101241
pii: S2352-8273(22)00220-8
pmc: PMC9530956
doi:
Types de publication
Journal Article
Langues
eng
Pagination
101241Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Int J Obes (Lond). 2006 Feb;30(2):281-7
pubmed: 16331302
J Epidemiol Community Health. 2004 Aug;58(8):686-91
pubmed: 15252072
N Engl J Med. 2001 Jul 12;345(2):99-106
pubmed: 11450679
Am J Epidemiol. 1999 May 15;149(10):898-907
pubmed: 10342798
Am J Public Health. 1998 Jun;88(6):973-6
pubmed: 9618634
Epidemiology. 1997 Jan;8(1):42-7
pubmed: 9116094
Soc Sci Med. 1995 Oct;41(7):935-47
pubmed: 8545668
BMC Public Health. 2012 Apr 03;12:266
pubmed: 22471945
J Epidemiol Community Health. 2014 Aug;68(8):712-9
pubmed: 24675289
J Pers Soc Psychol. 2005 Dec;89(6):852-63
pubmed: 16393020
Prev Med. 2021 Jun;147:106506
pubmed: 33677028
N Engl J Med. 2011 Oct 20;365(16):1509-19
pubmed: 22010917
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
Pharmacol Res. 2016 Nov;113(Pt A):600-609
pubmed: 27697647
BMJ. 2021 Apr 14;373:n604
pubmed: 33853828
Am J Epidemiol. 1987 Jun;125(6):989-98
pubmed: 3578257
Glob Heart. 2016 Dec;11(4):393-397
pubmed: 27938824
Lancet Glob Health. 2019 Jun;7(6):e748-e760
pubmed: 31028013
Int J Obes Relat Metab Disord. 1997 Apr;21(4):304-8
pubmed: 9130028
Scand J Public Health. 2022 May 4;:14034948221092294
pubmed: 35509230
Am J Epidemiol. 2017 Jul 15;186(2):184-193
pubmed: 28472328
Int J Environ Res Public Health. 2014 Oct 16;11(10):10663-93
pubmed: 25325355
Scand J Public Health. 2021 Dec 13;:14034948211059972
pubmed: 34903094
JAMA. 2005 Jul 27;294(4):466-72
pubmed: 16046653
Am J Public Health. 1998 Nov;88(11):1709-12
pubmed: 9807543
Acta Med Scand. 1976;200(1-2):107-118
pubmed: 785953
Int J Epidemiol. 2012 Aug;41(4):961-7
pubmed: 21422063
Soc Sci Med. 2018 Aug;211:282-293
pubmed: 29966823
Soc Sci Med. 1999 Feb;48(4):497-505
pubmed: 10075175
Int J Epidemiol. 2022 Jan 6;50(6):1959-1969
pubmed: 34999857
Soc Sci Med. 1997 Sep;45(6):893-902
pubmed: 9255922
Soc Sci Med. 2008 Jun;66(12):2596-609
pubmed: 18359137
Int J Behav Nutr Phys Act. 2017 Feb 6;14(1):15
pubmed: 28166790
J Epidemiol Community Health. 1998 Jun;52(6):399-405
pubmed: 9764262
BMC Public Health. 2014 Aug 09;14:825
pubmed: 25106746
J Epidemiol Community Health. 2010 Jun;64(6):542-8
pubmed: 19825786
J Epidemiol Community Health. 1995 Dec;49 Suppl 2:S72-7
pubmed: 8594138
Lancet. 2004 Sep 11-17;364(9438):937-52
pubmed: 15364185
Scand J Med Sci Sports. 2015 Dec;25 Suppl 4:119-25
pubmed: 26589125
Arch Public Health. 2022 Mar 9;80(1):75
pubmed: 35264230
Annu Rev Psychol. 2011;62:501-30
pubmed: 20636127
Food Nutr Res. 2019 Dec 10;63:
pubmed: 32082100